Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation.
Sung-Eun LeeJi-Young LimTae Woo KimDa-Bin RyuSung Soo ParkYoung-Woo JeonJae-Ho YoonByung-Sik ChoKi-Seong EomYoo-Jin KimHee-Je KimSeok LeeSeok-Goo ChoDong-Wook KimJong Wook LeeChang-Ki MinPublished in: Journal for immunotherapy of cancer (2019)
Our data demonstrate that pre-ASCT M-MDSCs are correlated with poor clinical outcomes after ASCT through reduced cytotoxicity of melphalan. We propose that targeting CSF1R on these cells may improve the results of ASCT in MM.